Hawaii HB872 authorizes various entities to stock and administer auto-injectable epinephrine for anaphylaxis emergencies.
HB872 aims to increase access to epinephrine by allowing entities like schools, businesses, and government offices to stock auto-injectable epinephrine. Practitioners can prescribe epinephrine for these entities, which can then train employees to administer it. The bill also provides immunity from liability for those administering epinephrine in good faith, except in cases of misconduct. The Department of Health will oversee the program, including setting storage and training requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.